Straub, R. H. and Elbracht, R. and Krämer, Bernhard K. and Roth, M. and Palitzsch, K. D. and Schölmerich, J.
Influence of digoxin-like immunoreactive factor on late complications in patients with diabetes mellitus.
European journal of clinical investigation 24 (7), pp. 482-487.
The aim of this study was to compare the intensity of typical late complications in diabetic patients (n = 65, 28 type I, 37 type II) who were not on glycoside drugs with low vs. high serum levels of digoxin-like immunoreactive factor (DLIF: group I, n = 42, DLIF < or = the detection limit of 0.2 ng ml-1; and group II, n = 23, mean +/- SEM: 1.17 +/- 0.31 [0.25-4.96] ng ml-1). For detection of ...
Export bibliographical data
|Diabetes Mellitus, Type 1/complications||MESH|
|Diabetes Mellitus, Type 2/complications||MESH|
|Severity of Illness Index||MESH|
|Dewey Decimal Classification:||600 Technology > 610 Medical sciences Medicine|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Unknown|
|Deposited On:||08 Sep 2011 06:36|
|Last Modified:||13 Mar 2014 17:59|